DaVita Inc. Profile Avatar - Palmy Investing

DaVita Inc.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatie…

Medical - Care Facilities
US, Denver [HQ]

Ratios

15 Records · Starting from 2009
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
30.45 30.60 31.08 31.85 30.31 28.73 28.71 27.79 29.76 28.14 30.50 30.84 31.38 29.29 25.33
Profit Margin
6.92 6.29 7.04 6.55 5.38 5.65 1.96 5.97 6.10 6.93 7.12 6.70 8.42 6.62 5.70
Operating Margin
15.39 15.46 16.65 15.84 13.18 14.19 8.49 12.85 16.67 13.38 14.43 14.67 15.47 11.53 13.19
EPS Growth
14.61 -1.96 26.00 10.71 8.24 12.91 -62.76 243.31 -19.27 31.53 14.26 23.63 42.20 -11.18 -7.75
Return on Assets (ROA)
5.59 5.00 5.38 3.34 3.70 4.03 1.46 4.69 3.50 4.13 4.68 4.55 5.71 4.54 3.92
Return on Equity (ROE)
19.80 20.51 22.33 14.24 14.29 13.99 5.54 18.93 14.15 21.33 38.01 55.92 129.51 107.84 65.48
Return on Invested Capital (ROIC)
10.26 10.27 11.00 6.75 7.98 8.75 4.94 9.55 9.93 8.33 9.46 10.26 11.27 8.49 13.52
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
48.46 53.41 50.66 53.32 49.22 47.39 49.40 48.62 49.27 52.86 64.56 65.89 69.94 69.84 48.63
Debt/Equity
171.56 219.07 210.41 227.32 189.87 164.46 187.45 196.05 199.07 272.78 523.85 809.07 1,585.06 1,659.70 811.38
Debt/EBITDA
267.13 282.11 289.10 490.93 368.57 326.20 385.46 325.91 366.88 468.62 417.52 460.93 463.43 563.18 453.95
Debt/Capitalization
63.18 68.66 67.78 69.45 65.50 62.19 65.21 66.22 66.56 73.17 83.97 89.00 94.07 94.32 89.03
Interest Debt per Share USD
18.57 22.61 25.07 46.05 42.14 41.99 45.02 47.25 51.78 62.01 75.86 95.98 116.51 130.97 97.73
Debt Growth
-0.87 18.32 3.94 89.89 -1.62 1.04 7.37 -0.20 2.46 8.20 10.63 0.16 6.98 -1.28 -5.97
Liquidity
Current Ratio
219.93 283.75 197.86 142.73 141.03 185.61 189.29 147.61 287.53 172.23 155.57 127.16 132.07 120.44 118.76
Quick Ratio
184.85 246.31 162.70 113.03 113.63 158.63 173.41 133.69 88.42 55.67 144.13 112.43 120.69 109.65 109.46
Cash Ratio
51.53 93.05 34.15 26.24 38.43 46.21 63.35 33.87 16.71 6.60 46.47 13.12 19.26 9.32 17.59
Operating Cash Flow Ratio
- - - - 100 - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
6,065.97 5,887.19 6,180.79 7,140.84 9,231.89 6,701.18 5,294.27 6,458.13 4,202.45 7,632.18 8,080.21 7,156.65 7,421.17 7,523.28 6,334.62
Receivables Turnover
446.11 462.62 463.62 465.55 637.77 636.38 627.42 619.18 508.94 475.79 494.06 473.61 482.01 455.17 502.51
Payables Turnover
2,405.04 2,471.78 1,615.99 1,347.08 1,882.67 2,047.20 1,945.56 2,037.98 1,500.64 1,769.06 1,959.81 1,839.62 1,982.95 1,711.11 1,761.82
Asset Turnover
80.82 79.46 76.38 51.03 68.80 71.31 74.57 78.68 57.40 59.68 65.79 67.99 67.86 68.58 68.90
Coverage
Interest Coverage
506.19 389.48 469.03 449.51 360.54 442.40 286.67 457.20 420.95 313.03 370.26 557.24 630.09 375.07 526.37
Asset Coverage
100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
Cash Flow Coverage (CFGR)
18.20 19.37 26.19 12.87 21.07 17.16 17.06 21.55 20.43 17.54 18.54 17.68 16.12 13.23 24.09
EBITDA Coverage
600 400 500 500 400 500 400 600 500 400 500 700 800 500 700
Dividend Coverage
-600 -400 - - - - - - - - - - - - - - - - - - - - - - - - - -
Time Interest Earned (TIE)
200 200 200 100 100 100 100 100 200 100 200 100 100 100 200
Market Prospects
Dividend Yield
1.11 1.19 - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Yield
6.95 5.75 6.66 5.05 4.76 4.50 1.83 6.80 4.87 8.99 7.06 5.50 8.17 11.06 7.27
Price/Earnings (P/E)
14.3977 17.3868 15.0126 19.7995 21.0024 22.2368 54.7555 14.7127 20.5362 11.1238 14.1719 18.1792 12.2346 9.0390 13.7537
Price/Book (P/B)
285.04 356.52 335.16 282.02 300.14 310.99 303.22 278.51 290.58 237.31 538.72 1,016.52 1,584.49 974.79 900.60
Price/Sales (P/S)
99.62 109.40 105.65 129.64 113.09 125.67 107.16 87.79 125.30 77.06 100.92 121.76 103.03 59.81 78.34
Price/Cash Flow (P/CF)
912.79 840.02 608.11 964.06 750.21 1,101.80 948.45 659.32 714.47 496.07 554.59 710.66 619.98 443.81 460.82
End of DVA's Analysis
CIK: 927066 CUSIP: 23918K108 ISIN: US23918K1088 LEI: - UEI: -
Secondary Listings